tert-Butyl 2-(6-(dimethylamino)pyridin-3-yl)piperidine-1-carboxylate

Catalog No. :
ACZSZB526
CAS No. :
1352526-29-4
Molecular Formula :
C17H27N3O2
Molecular Weight :
305.42

IUPAC Name:tert-butyl 2-(6-(dimethylamino)pyridin-3-yl)piperidine-1-carboxylate

tert-Butyl 2-(6-(dimethylamino)pyridin-3-yl)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$985.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 2-(6-(dimethylamino)pyridin-3-yl)piperidine-1-carboxylate
IUPAC Nametert-butyl 2-(6-(dimethylamino)pyridin-3-yl)piperidine-1-carboxylate
Molecular FormulaC17H27N3O2
Molecular Weight305.42
SMILESO=C(N1CCCCC1C2=CC=C(N(C)C)N=C2)OC(C)(C)C
InChI KeyCBHZBXPXYAJSDZ-UHFFFAOYSA-N
Synonym6-Dimethylamino-3,4,5,6-tetrahydro-2H-[2,3]bipyridinyl-1-carboxylic acid tert-butyl ester;tert-Butyl 2-(6-(dimethylamino)pyridin-3-yl)piperidine-1-carboxylate;1-Piperidinecarboxylic acid, 2-[6-(dimethylamino)-3-pyridinyl]-, 1,1-dimethylethyl ester
CAS No.1352526-29-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACZSZB526 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZSZB526 route product structure diagram
    ACZSZB5261352526-29-4
Inquiry

2. ACZSZB526 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZSZB526 route product structure diagram
    ACZSZB5261352526-29-4
Inquiry

Comments (0)